BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27659555)

  • 1. Detrimental effect of clomipramine on hippocampus-dependent learning in an animal model of obsessive-compulsive disorder induced by sensitization with d2/d3 agonist quinpirole.
    Hatalova H; Radostova D; Pistikova A; Vales K; Stuchlik A
    Behav Brain Res; 2017 Jan; 317():210-217. PubMed ID: 27659555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder.
    Janikova M; Brozka H; Radostova D; Svoboda J; Stuchlik A
    Physiol Behav; 2019 May; 204():241-247. PubMed ID: 30826389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial reversal learning in chronically sensitized rats and in undrugged sensitized rats with dopamine d2-like receptor agonist quinpirole.
    Hatalova H; Radostova D; Pistikova A; Vales K; Stuchlik A
    Front Behav Neurosci; 2014; 8():122. PubMed ID: 24782730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD.
    Eagle DM; Noschang C; d'Angelo LS; Noble CA; Day JO; Dongelmans ML; Theobald DE; Mar AC; Urcelay GP; Morein-Zamir S; Robbins TW
    Behav Brain Res; 2014 May; 264(100):207-29. PubMed ID: 24406720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder.
    Tizabi Y; Louis VA; Taylor CT; Waxman D; Culver KE; Szechtman H
    Biol Psychiatry; 2002 Jan; 51(2):164-71. PubMed ID: 11822995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model.
    Szechtman H; Culver K; Eilam D
    Pol J Pharmacol; 1999; 51(1):55-61. PubMed ID: 10389145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Perreault ML; Seeman P; Szechtman H
    Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals.
    Eilam D; Szechtman H
    CNS Spectr; 2005 Mar; 10(3):191-202. PubMed ID: 15744221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD).
    Szechtman H; Sulis W; Eilam D
    Behav Neurosci; 1998 Dec; 112(6):1475-85. PubMed ID: 9926830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of animal models of obsessive-compulsive disorder: correlation with phasic dopamine neuron activity.
    Sesia T; Bizup B; Grace AA
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1295-307. PubMed ID: 23360787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective serotonin reuptake inhibitor ameliorates obsessive-compulsive disorder-like perseverative behavior by attenuating 5-HT
    Hatakama H; Asaoka N; Nagayasu K; Shirakawa H; Kaneko S
    Neuropharmacology; 2022 Mar; 206():108926. PubMed ID: 34921828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior.
    De Carolis L; Schepisi C; Milella MS; Nencini P
    Psychopharmacology (Berl); 2011 Dec; 218(4):749-59. PubMed ID: 21660444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasticity-Related Activity in the Hippocampus, Anterior Cingulate, Orbitofrontal, and Prefrontal Cortex Following a Repeated Treatment with D
    Brozka H; Alexova D; Radostova D; Janikova M; Krajcovic B; Kubík Š; Svoboda J; Stuchlik A
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33440912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Sharma R; Taji L; Cheon P; Peel J; Kirk A; Szechtman H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3707-18. PubMed ID: 24682503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit.
    Alkhatib AH; Dvorkin-Gheva A; Szechtman H
    Behav Pharmacol; 2013 Feb; 24(1):65-73. PubMed ID: 23249525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Johnson E; Wong M; Szechtman H
    Behav Brain Res; 2015 Feb; 279():211-7. PubMed ID: 25449840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Tucci MC; Dvorkin-Gheva A; Graham D; Amodeo S; Cheon P; Kirk A; Peel J; Taji L; Szechtman H
    Psychopharmacology (Berl); 2013 May; 227(2):277-85. PubMed ID: 23354534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders guidelines for the treatment of adult obsessive-compulsive disorder. Part I: pharmacological treatment.
    de Oliveira MVS; de Barros PMF; de Mathis MA; Boavista R; Chacon P; Echevarria MAN; Ferrão YA; Vattimo EFQ; Lopes AC; Torres AR; Diniz JB; Fontenelle LF; Rosário MCD; Shavitt RG; Miguel EC; da Silva RMF; Costa DLDC
    Braz J Psychiatry; 2023 May; 45(2):146-161. PubMed ID: 36749887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.